A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
https://pubmed.ncbi.nlm.nih.gov/33451982/ Cancer Discov. 2021 Jun;11(6):1562-1581. doi: 10.1158/2159-8290.CD-20-1109. Epub 2021 Jan 15. Yuan-Hung Lo 1, Kevin S Kolahi 2, Yuhong Du 3, Chiung-Ying Chang 2, Andrey Krokhotin 4, Ajay Nair 5, Walter D Sobba 1, Kasper Karlsson 1 6, Sunny J Jones 5, Teri A Longacre 2, Amanda T Mah 1, Bahar Tercan 7, Alexandra Sockell 6, Hang Xu 6, Jose A Seoane 6, Jin Chen 8 9, Ilya Shmulevich 7, Jonathan S Weissman 8, Christina Curtis 6, Andrea Califano 5, Haian Fu 3, Gerald R Crabtree 2 4 10, Calvin J Kuo 11Affiliations expand PMID: 33451982 PMCID: PMC8346515 DOI: 10.1158/2159-8290.CD-20-1109 Abstract Mutations in ARID1A rank among the most common molecular …